Form 4 for TXG 10x Genomics, Inc.
Accepted 2024-02-20 00:00:00 ET · period of report 2024-02-15 · accession 0001610717-24-000071 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2024-02-20 | 2024-02-15 | TXG | Saxonov Serge | CEO, Dir | S - Sale | $48.87 | -5,000 | 850.4K | -0.6% | -$244.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-02-15 | S | D | 3,300 | $48.58 | 852,081 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $48.08 to $49.02. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 2 | Common | Class A Common Stock | 2024-02-15 | S | D | 1,700 | $49.43 | 850,381 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $49.10 to $49.57. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |